Kymera Therapeutics Files 2025 Annual Report
Ticker: KYMR · Form: ARS · Filed: Apr 29, 2026 · CIK: 0001815442
| Field | Detail |
|---|---|
| Company | Kymera Therapeutics, Inc. (KYMR) |
| Form Type | ARS |
| Filed Date | Apr 29, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, sec-filing, biotechnology
TL;DR
Kymera Therapeutics filed its 2025 ARS on 4/29/26. Check it for 2025 performance.
AI Summary
Kymera Therapeutics, Inc. filed its Annual Report to Security Holders (ARS) on April 29, 2026, for the period ending December 31, 2025. The filing, with accession number 0001193125-26-191619, details the company's operations and financial standing for the fiscal year 2025. Kymera Therapeutics, Inc. is a biotechnology company focused on biological products.
Why It Matters
This filing provides shareholders and potential investors with a comprehensive overview of Kymera Therapeutics' performance and strategic direction for the fiscal year 2025.
Risk Assessment
Risk Level: low — This is a routine annual report filing and does not contain new material events or significant financial changes that would indicate a high risk.
Key Numbers
- 1202938 — ARS PDF Size (Size of the main ARS document in bytes)
- 1658174 — Text File Size (Size of the complete submission text file in bytes)
Key Players & Entities
- Kymera Therapeutics, Inc. (company) — Filer of the ARS
- 0001815442 (company) — CIK number for Kymera Therapeutics, Inc.
- 0001193125-26-191619 (dollar_amount) — SEC Accession Number for the filing
- 2026-04-29 (date) — Filing Date and Acceptance Date
- 2025-12-31 (date) — Period of Report
FAQ
What is the primary purpose of an ARS filing?
An ARS (Annual Report to Security Holders) filing provides shareholders with a comprehensive overview of the company's performance, financial statements, and other relevant information for the past fiscal year.
What fiscal year does this ARS filing cover?
This ARS filing covers the period ending December 31, 2025.
When was this ARS filing accepted by the SEC?
This ARS filing was accepted by the SEC on April 29, 2026.
What is Kymera Therapeutics, Inc.'s CIK number?
Kymera Therapeutics, Inc.'s CIK number is 0001815442.
What industry is Kymera Therapeutics, Inc. primarily involved in?
Kymera Therapeutics, Inc. is primarily involved in Biological Products, specifically SIC code 2836 (Biological Products, No Diagnostic Substances).
Filing Details
This Form ARS (Form ARS) was filed with the SEC on April 29, 2026 regarding Kymera Therapeutics, Inc. (KYMR).